97
Views
8
CrossRef citations to date
0
Altmetric
REVIEWS

Bioelectric and Biomagnetic Methods for Cancer Research and Therapy—A Survey

Pages 423-440 | Published online: 07 Jul 2009

References

  • Berg, H. Problems of weak electromagnetic field effects in cell biology. Bioelectrochem. Bioenerg. 1999, 48, 355–360. [PUBMED], [INFOTRIEVE], [CSA]
  • Jaroszeski, M.; Heller, R.; Gilbert, R. Electrochemotherapy, Electrogenetherapy, Electrically Mediated Delivering of Molecules to Cells and Transdermal Drug Delivery. Humana Press: Totowa, 2000.
  • Rosch, P.; Markov, M. Bioelectromagnetic Medicine. M. Dekker: NY, 2004.
  • Nordenström, B. Biological closed electric circuits, clinical, experimental, and theoretical evidents for an additional circulatory system. Nordic Medical Publications: Stockholm, 1983.
  • Long, Y.; Cai, G.; Guan, Z.; , et al. Effects of electromagnetic fields on the bioactivities on an osteoblast-like cell line (UMR-1106). Electro-Magnetobiol. 2000, 19, 237–253. [CSA]
  • Radeva, M.; Berg, A.; Berg, H. Induction of apoptosis and necrosis in cancer cells by electric fields, electromagnetic fields, and photodynamically active quinoids. Electromagnetic Biol. Medic. 2004, 23, 1–16. [CSA], [CROSSREF]
  • Nickoloff, J. Animal Cell Electroporation and Electrofusion Protocolls. Humana Press: Totowa, 1995.
  • Sersa, G.; Cemezar, M.; Rudolf, Z. Electrochemotherapy: advances and drawbacks in treatment of cancer patients (Rev.). Cancer Therapy 2003, 1, 133–142. [CSA]
  • Gothelf, A.; Mir, L. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treatment Res. 2003, 20, 1–17. [CSA]
  • Zhang, X.; Zhang, H.; Zheng, C.; , et al. Extremely low frequency pulsed gradient magnetic fields inhibit malignant tumor growths at different biological levels. Coll. Biol. Int. 2002, 26, 599–03. [CSA], [CROSSREF]
  • Dev, S.; Rabussay, D.; Widera, G.; , et al. Medical application of electroporation. IEEE Transact. Plasma Sci. 2000, 28, 206–223. [CSA], [CROSSREF]
  • Lambreva, M.; Glück, B.; Radeva, M.; , et al. Electroporation of cell membranes supporting penetration of photodynamically active macromolecular chromophor dextrans. Bioelectrochemistry 2004, 62, 95–98. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Liboff, A.; Jenrow, K. Cell sensitivity to magnetic fields. Electro-Magnetobiol. 2000, 19, 223–236. [CSA]
  • Mc Cann, J.; Dietrich, F.; Rafferty, C. The genotoxic potential of electric and magnetic fields, an uptake. Mutation Res. 1998, 411, 45–86. [CSA], [CROSSREF]
  • Radeva, M.; Berg, H. Differences in lethality between cancer cells and human lymphcytes caused by electromagnetic fields. Bioelectromagnetics 2004, 25, 503–507. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Simko, M.; Kriehuber, R.; Weiss, D.; , et al. Effects of 50 Hz EMF exposure on micronuleus formation and apoptosis in transformed and nontransformed human cell lines. Bioelectrochemistry 1998, 19, 85–91. [CSA]
  • Berg, H. Milestones of bioelectromagnetics: monographs annd proceedings. Electromagn. Biol. Medicine 2004, 25, 181–184. [CSA]
  • Binhi, V. Magnetobiology-underlying Physical Problems. Elsevier: NY, 2002.
  • Mijakoshi, J.; Takemasa, K. Effect of exposure to a 1950 MHz radio frequency field on expression of HSP-70 and HSP-27 in human glioma cells. Bioelectromagnetics 2005, 26, 251–257. [CSA], [CROSSREF]
  • Velizarov, S.; Raskmark, P.; Kwee, S. The effects of radio frequency fields on cell proliferation are non-thermal. Bioelectrochem. Bioenerg. 1999, 48, 177–180. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sonntag, W.; Weibzahn, K. Influence of low frequency electric fields on proliferation and IL-8 release of HL-60 cells. Electromagn. Biol. Medic. 2002, 21, 119–128. [CSA], [CROSSREF]
  • Ghannam, M.; El-Gebaly, R.; Gaber, M.; , et al. Inhibition of Ehrlich tumor growth in mice by electric interference therapy. Biol. Medicine 2002, 21, 255–268. [CSA]
  • Aldinucci, C.; Garcia, J.; Palmi, M.; , et al. The effect of strong magnetic field on lymphocytes. Bioelectromagnetics 2003, 24, 109–117. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Neumann, E.; Kakorin, S. Digression on membrane eletroporation and electroporative delivery of drugs and genes. Radiol. Oncolog. 1998, 32, 7–17. [CSA]
  • Zhang, L.; Rabussay, D. Clinical evaluation of safety and human tolerance of electrical sensation induced by electric fields with non-invasive electrodes. Bioelectrochemistry 2002, 56, 233–236. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Elez, R.; Piiper, A.; Kronenberger, B.; , et al. Tumor regression by combination antisense therapy agaist Plk-1 and Bcl-2. Oncogene 2003, 22, 69–80. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Mir, L.; Behleradek, M.; Domenge, C.; , et al. L' électrochimiothérapie, un noveau traitement antitumoral: premier essai clinique. C. R. Acad. Sci. Paris 1991, 313, 613–618. [PUBMED], [INFOTRIEVE], [CSA]
  • Radeva, M.; Lambreva, M.; Angelova, P.; , et al. Synergism of electric and electromagnetic fields and photodynamic effects induce apoptosis and necrosis of cancer cells. Electrochemistry (China) 2004, 10, 260–270. [CSA]
  • Hisamitsu, T.; Narita, K.; Kasahara, T.; , et al. Induction of apoptosis in human Leukemia cells by magnetic fields. Jpn. J. Physiol. 1997, 47, 307–310. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Pang, L.; Traitcheva, N.; Gothe, G.; , et al. ELF electromagnetic fields inhibit proliferation of human cancer cells and induce apoptosis. Electromagn. Biol. Med. 2002, 21, 243–248. [CSA], [CROSSREF]
  • Traitcheva, N.; Angelova, P.; Radeva, M.; , et al. ELF fields and photooxidation yielding Lethal effects on cancer cells. Bioelectromagnetics 2003, 24, 148–150. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ardenne, M. Systemische Krebs-Mehrschritt-Therapie. Verlag: Stuttgart, Hippokrates, 1997.
  • Czyz, J.; Nikolova, T.; Schuderer, J.; , et al. Nonthermal effects of power line magnetic fields (50 Hz) on gene expression levels of pluripotent embrionic stem cells – the role of the tumor suppressor p53. Mut. Res. 2004, 557, 63–74. [CSA]
  • Yoshizawa, H.; Tsuchya, T.; , et al. No effect of extremely electromagnetic field observed on cell growth or initial response on cell proliferation in human cancer cell lines. Bioelectromagnetics 2002, 23, 355–368. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gorgun, S.; , et al. Studies in interaction between electromagnetic fields and living matter neoplastic cell culture. Frontier Perspect. 1998, 7, 1–21. [CSA]
  • Liboff, A.; , et al. The charge and mass ICR signature in weak ELF bioelectromagnetic effects. In Advances in Electromagnetic Fields in Living Systems. Lin, J., Ed.; Kluwer/Plenum: NY.
  • Loberg, L.; Luther, M.; Ganger, I.; , et al. 60 Hz magnetic field do not enhance cell killing by genotoxic chemicals in Ataxia telangiectaxia and normal lymphoblastoids. Radiat. Res. 2000, 153, 685–690. [CSA]
  • Sauerwein, W.; Heselman, I.; Olthoff, K.; , et al. Can low intensity magnetic fields be used in cancer treatment? Bioelectrochem. Bioenerg. 1992, 27, 347–359. [CSA], [CROSSREF]
  • Stronati, L.; Testa, A.; Villani, P. Absence of genotoxicity in human blood cells exposed to 50 Hz magnetic fields as assesed by comet assay, chromosome aberration, micronucleus and sister chromatid exchange analysis. Bioelectromagnetics 2004, 25, 41–48. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rabussay, D.; Widera, G.; Burian, M.; , et al. Electroporation therapy: treatment of cancer and other therapeutic applications. In Bioelectric Medicine, Rosch, P., Markov, M., Eds.; M. Dekker: NY, 2004; 657–695.
  • Veija, V.; Nimrichter, L.; Teixeira, C.; , et al. Exposure of human leukemic cells to direct electric current: generation of toxic compounds inducing cell death by different mechanisms. Cell Biochem. Biophys. 2005, 42, 61–74. [CSA], [CROSSREF]
  • Jarm, T.; Cemezar, M.; Steinberg, F.; , et al. Perturbation of blood flow as a mechanism of antitumor action of direct current therapy. Physiol. Measurm. 203(24), 75–90. [CSA]
  • Xin, Y.; Zhao, H.; Zhang, W.; , et al. Electrochemical therapy of tumors. In Bioelectric Medicine. Rosch, P., Markov, M. Eds.; M. Dekker: NY, 2004.
  • Orlowsky, S.; Behleradek, J.; Paoletti, C.; , et al. Transient electropermealization of cells in culture: increase of cytotoxicity of anticancer drugs. Biochem. Pharmacol. 1988, 37, 4727–4733. [CSA], [CROSSREF]
  • Zhou, A.; Liu, M.; Baciu, C.; , et al. Membrane electroporation increases photodynamic effects. J. Electroanalyt. Chem. 2000, 486, 220–224. [CSA], [CROSSREF]
  • Nishi, T.; Yoshizato, K.; Yamashiro, S. High efficiency in vivo gene transfer using intraarterial injection following electroporation. Cancer Res. 1996, 56, 1050–1055. [PUBMED], [INFOTRIEVE], [CSA]
  • Sersa, G.; Miclavcic, D.; Cemezar, M.; , et al. Electrochemotherapy with CDDR on LPB sarcoma: comparison of the antitumor effectiveness in immuncompetent and immundeficient mice. Bioelectromagnetics 1997, 43, 279–283. [CSA]
  • Nanda, G.; Sun, F.; Hofmann, G.; , et al. Electroporation therapy of human larynx tumors HEp-2 implanted in nude mice. Anticancer Res. 1998, 18, 999–1004. [PUBMED], [INFOTRIEVE], [CSA]
  • Hyacinthe, M.; Jaroszeski, M.; Dand, V.; , et al. Electrically enhanced drug delivery for the treatment of soft tissue sarcoma. Cancer 1999, 85, 409–417. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Goto, T.; Nishi, T.; Tmura, T.; , et al. Highly efficient electrogene therapy of solid tumor by using an expresion plasmid for the herpes simplex thymidine kinase gene. PNAS 2000, 97, 354–359. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Yoshizato, K.; Nishi, T.; Goto, T. Gene delivery with optimized electroporation parameters shows potential for treatment gliomas. Int. J. Oncology 2000, 16, 899–905. [CSA]
  • Satkauskas, S.; Batiuskaite, S.; , et al. Effectiveness of tumor electrochemotherapy as a function of electric pulse strength and duration. Bioelectrochem 2005, 65, 105–111. [CSA], [CROSSREF]
  • Miclavcic, D.; Pucihar, G.; Pavlovec, M.; , et al. The effect of high frequency electric pulses on muscle contrations and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy. Bioelectrochemistry 2005, 65, 121–128. [CSA], [CROSSREF]
  • Sersa, G.; Stabuc, B.; Cemazar, M.; , et al. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clinical Cancer Res. 2000, 6, 863–867. [CSA]
  • Burian, M.; Formanek, M.; Regele, H. Electroporation therapy in head and neck cancer. Acta Otolaryngol 2003, 123, 264–268. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Simko, M.; , et al. Induction of cell activation processes by low frequency electromagnetic fields (review). The Scientific World J. 2004, 4, 4–22. [CSA]
  • Liang, Y.; Hannan, C.; Chang, B.; , et al. Enhanced potency of daunorubicin against multi drug resistance subline KB-CH-8-5-11 by a pulsed magnetic field. Anticancer Res. 1997, 17, 2083–2088. [PUBMED], [INFOTRIEVE], [CSA]
  • Schimmelpfeng, J.; Dertinger, H. Action of 50 Hz magnetic field on proliferation of cell culture. Bioelectromagnetics 1997, 18, 177–183. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Pipkin, J.; Hinson, W.; Young, J.; , et al. Induction of stress proteins by electromagnetic fields in cultured HL-60 cells. Bioelectromagnetics 1999, 20, 347–357. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Miyagi, N.; Sato, K.; Rong, Y.; , et al. Effects of PEMF on murine osteosarcoma cell line: drug resistance (P-glykoprotein positive) and non-resistance cells. Bioelectro-magnetics 2000, 21, 112–121. [CSA]
  • Glück, B.; Güntzschel, V.; Berg, H. Inhibition of proliferation of human lymphoma cells U937 by a 50Hz electromagnetic field. Cellul. Mol. Biol. 2001, 47, OL, 115–117. [CSA]
  • Tofani, S.; Barone, D.; Cintorino, M.; , et al. Static and ELF magnetic fields induce tumor growth inhibition and apoptosis. Bioelectromagnetics 2001, 22, 419–428. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Pirozzoli, M.; Marino, C.; Lovisolo, G.; , et al. Effect of 5 Hz electromagnetic field exposure on apoptosis and differentiation in a neuroblastoma cell line. Bioelectromagnetics 2003, 24, 510–516. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ivancsits, S.; Pilger, A.; Diem, E.; , et al. Cell type-specific genotoxic effects of intermittent Extremely low frequency electromagnetic fields. Mutat. Res. in press. [CSA]
  • Omote, Y.; Hosokawa, M.; Komatsumoto, M.; , et al. Treatment of experimental tumors with a combination of a pulsing magnetic field and an antitumor drug. Jpn. J. Cancer Res. 1990, 81, 956–961. [PUBMED], [INFOTRIEVE], [CSA]
  • Juraskova, V.; Vetterl, V.; Chromasta, O. Effect of Cd and electric and magnetic field on bone marrow and tumor cells. Bioelectrochem. Bioenerg. 1996, 39, 119–123. [CSA], [CROSSREF]
  • De Seze, Bonthes, C.; , et al. Effects of time–varying uniform magnetic fields on natural killer cell activity and antibody response in mice. Bioelectromagnetics 2000, 21, 107–111. [CSA], [CROSSREF]
  • Williams, D.; Marko, M. Therapeutic electromagnetic field effects on angiogenesis during tumor growth: a pilot study in mice. Electro-Magnetobiol. 2002, 20, 323–329. [CSA]
  • Tofani, S.; Cintorino, M.; Barone, D.; , et al. Increased mouse survival, tumor growth inhibition and decreased immunoreactive p53 after exposure to magnetic fields. Bioelectromagnetics 2002, 23, 230–238. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kraus, W. Treatment of pathological bone lesion with non-thermal extrem low Frequency electromagnetic field. Bioelectrochem. Bioenerg. 1992, 27, 321–339. [CSA], [CROSSREF]
  • Ronchetto, I.; Barone, D.; Cintorino, M.; , et al. Extremely low frequency-modulated static magnetic fields to treat cancer: a pilot study on patients with advanced neoplasm to assass safety and acute toxicity. Bioelectromagnetics 2004, 25, 563–571. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rabussay, D.; Dev, N.; Fewell, J.; , et al. Enhancement of therapeutic drug and DNA delivery into cells by electroporation. J. of Physics D: Appl. Phys. 2003, 36, 348–363. [CSA], [CROSSREF]
  • Tofani, S.; Barone, D.; Peano, S. , et al. Anticancer activity by magnetic fields: inhibition of metastatic spread and growth in a breast cancer model. IEEE Transact. Plasma Sci 2002, 30, 1552–1557. [CSA], [CROSSREF]
  • Zhang, L. In vivo skin-targeted gene delivery by pulsed electric fields. In Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Jaroszeski, M., Heller, R., Gilbert, R. Eds.; Humana Press: Totowa, 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.